IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abingworth LLP

Q2 2021 Holdings

Filed 2021-08-16 | 19 holdings | $323.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vaxcyte(PCVX)Common92243G108$93.6K4,168,71828.9%
Phathom(PHAT)Common71722W107$40.7K1,203,13512.6%
Vera(VERA)Common92337R101$38.5K2,960,23111.9%
Spruce BioCommonE5209E109$20.1K1,792,5186.2%
SientraCommon82621J105$19.0K2,390,8435.9%
Reneo(RPHM)Common75974E103$18.2K1,962,2215.6%
Sierra OncologyCommon82640U107$16.8K871,1255.2%
Adicet(TORCEUR)Common007002108$16.6K1,615,3855.1%
Verona(VRNA)SPONDS ADR925050106$16.0K2,457,4994.9%
SolenoCommon834203200$11.6K10,302,6023.6%
Exicure(XCUR)Common30205M101$10.4K6,977,0003.2%
NucanaADR67022C106$9.2K3,333,3332.8%
ParatekCommon699374302$7.1K1,041,1312.2%
Aeglea(AGLEUSD)Common00773J103$1.7K240,5000.5%
Molecular TemplatesCommon608550109$1.6K200,0000.5%
X4 Pharma(ASNSUSD)Common98420X103$1.5K229,8850.5%
Cymabay(CBAYUSD)Common23257D103$571131,0360.2%
ObsevaCommonH5861P103$26687,9990.1%
OcugenCommon43358V109$577,1110.0%